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T cell lines (B13, B19) were isolated from the lymph nodes of Lewis rats 12 days after an 
arthritogenic injection of cell wall fragments of Eubacterium aerofaciens (ECW), a major resident 
of the human intestinal flora. These cell wall fragments consist of peptidoglycan polysaccharide 
complexes (PPC). The cell lines that bear the helper phenotype were arthritogenic in knee or 
ankle joints upon intravenous injection into irradiated Lewis recipients. B 13 was, however, not 
arthritogenic in irradiated F344 recipients that are largely RTl identical. The arthritis induced 
in the knee joints of the irradiated Lewis rats was clearly shown by a 99mtechnetium-pertechnetate 
scanning technique and was confirmed histologically. In vitro the cell lines showed a proliferative 
response after stimulation with syngeneic spleen cells alone. The proliferation was significantly 
higher when bacterial PPC, isolated in soluble form from normal feces or ileostomy fluid were 
added. Recognition by B 13 appeared to be MHC class II restricted. These results show that 
autoreactive T cell lines can be isolated from rats after injection of bacterial cell wall antigens 
and that these cell lines can be arthritogenic. This suggests a role for autoreactive T cells in the 
induction of bacterial cell wall arthritis and might give a clue for the arthritogenic properties of 
the normal human intestinal flora. 0 1992 Academic FYLX, Inc. 
INTRODUCTION 
A trigger role for intestinal bacterial antigens in the etiology of rheumatic disease 
has been hypothesized by Bennett (1) and has been supported by others (2-4). Several 
observations affirm this hypothesis in man, e.g., the arthritis developing in obese patients 
after intestinal bypass surgery (5) the arthritis in 15% of the patients suffering from 
Crohn’s disease (6), and in patients infected with Yersinia, Salmonella, or Shigella (7). 
The arthritis-inducing capacity of bacterial antigens and the role of T cells in the 
induction of arthritis have been investigated in rat models. In the Mycobacterium 
tuberculosis (MT)’ model, in which Lewis rats develop arthritis upon subcutaneous 
injection of MT in incomplete Freund’s adjuvant (8), a T cell clone (A2b) has been 
isolated from arthritic rats that was capable of transfening the disease (9, 10). The 
arthritogenic apacity of this T cell clone has been explained by cross reactivity between 
i Abbreviations used: CM, complete medium; ECW, Eubacterium aerofaciens cell walls; GF, germ-free; 
MDP, muramyl dipeptide; MT, Mycobacterium tuberculosis; NT, not tested; PPC, peptidoglycan polysac- 
charide complex; SCW, Streptococcus pyogenes cell walls. 
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9 amino acids of the 65-kDa heat shock protein of MT and cartilage (11, 12). At 
present, there is more interest in the cross-reactivity between exogenous and endogenous 
heat shock proteins (13). 
In another model using streptococcal cell wall fragments (SCW), Lewis rats are very 
susceptible to arthritis induction by intraperitoneal injection of SCW (14). Involvement 
of T cells in the arthritis induced in this model is clear as chronic arthritis is not 
inducible in nude rats (1516) and cyclosporin A has been shown to reduce the severity 
of the disease (17). A T cell line recognizing both SCW and MT, but not the 65-kDa 
protein, recently has been found to be arthritogenic in a passive transfer system (18). 
A correlation between T cell responses on SCW and the 65-kDa protein has however 
been described by van den Broek et al. (19, 20). 
In our model, which is based on the SCW model and the hypothesis stated by 
Bennett, we have used cell wall fragments from the anaerobic Gram-positive major 
residents of the human intestinal flora. These bacteria form the largest pool of bacteria 
with which we are in a lifelong close contact. We have recently shown (21-24) that 
these cell wall fragments can be arthritogenic after ip injection in Lewis rats. Intra- 
peritoneal injection of peptidoglycan polysaccharide complexes (PPC) of the cell walls 
of the major resident Eubacterium aerofaciens (ECW), that is present in numbers 
higher than lO”/gram in the human feces, cause a chronic arthritis that lasts for 
several months and often never wanes completely (22-24). Injection of ECW in IFA 
in the base of the tail of Lewis rats also induces arthritis (to bepublished). Lehman 
et al. reported on the arthropatic properties of Lactobaccilus species (25, 26), while 
Stimpson et al. chose S. facium, P. productus, P. acnes, and M. formicum as repre- 
sentatives of the human indigenous flora (27). These microorganisms, however, do 
not represent he group of major bowel residents. 
PPCs were shown to be present in soluble form in feces of healthy subjects and 
patients suffering of Crohn’s disease (28). PPC isolated from the ileostomy fluid was 
arthritogenic when 1 mg was injected in the base of the tail in IFA (29). 
As we were interested in the capacity of T cells from arthritic rats in our model, 
using intestinal bacterial cell wall antigens to transfer the disease, we have made T 
cell lines using these antigens. The arthritogenic apacities and in vitro characteristics 
of these T cell lines, that appear to be different from the lines described above, might 
give insight into the mechanisms involved in the arthritis caused by intestinal bacterial 
cell wall antigens. 
MATERIALS AND METHODS 
Rats. Lewis and F344 (RTl’) rats were obtained from the Zentral Institute fur 
Versuchstierzucht (Hannover, FRG). RP rats (RTlA”B’) were obtained from the 
breeding stock of the Erasmus University, Rotterdam, and Wag rats (RTl”) were 
obtained from ITRI-TNO, Rijswijk, The Netherlands. Germ-free (GF) F344 rats were 
obtained from the University of Nijmegen, The Netherlands. Female rats were used 
at 8-12 weeks of age. 
Isolation and maintenance of the T cell lines. B 13 was cultured from lymph nodes 
of five Lewis rats, 12 days after injection of ECW (25 pg muramic acid/g body wt), 
B19 came from the LN of a Lewis rat 12 days after injection of 1 mg ECW in 100 ~1 
IFA in the base of the tail. Both were cultured in RPM1 1640 (GIBCO, Paisley, Scotland) 
with 25 mM Hepes, 100 U/ml penicillin, 100 bg/ml streptomycin, 50 I.& /3-mercap- 
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toethanol, and 10% FCS (complete medium (CM)) containing 30 pg/ml ECW (based 
on muramic acid content). They were restimulated weekly by dilution in fresh CM 
and addition of 30 pg/ml ECW and 3 X lo*-lo6 30.0 Gy-irradiated syngeneic spleen 
cells (erythrocytes lysed by 155 mM NH&l with 10 mM KHC03, and 10 mM EDTA 
for 3 min at 4°C). Three days later the cells were transferred to CM with 40-100 U/ 
ml recombinant human IL-2 (recIL2, kind gift of Dr. J. Besemer, Sandoz, Vienna, 
Austria). The first two to three restimulation cycles after isolation of the LN, the bulk 
cultures did not receive recIL-2. The cells were diluted twice a week (at the day of 
restimulation and at 3 days after restimulation), resulting in a weekly dilution of the 
cells of about five times. 
Proliferation assays. In the proliferation assays 2 X lo4 cells per well were tested 
and 6 X 104-2 X lo5 syngeneic spleen cells were added in the presence of various 
antigens. The proliferation assays were performed for 4 days in round-bottom microtiter 
plates (Costar, Cambridge, UK). In the last 17 hr of culture 7.4 kBq 13H]thymidine 
was added (sp act 74 GBq/mmol, Amersham, Buckinghamshire, UK). The cultures 
were harvested by means of an automatic cell harvester (Costar) and counted in a 
beta counter (Packard, Brussels, Belgium) or later on in a beta plate (Pharmacia, LKB, 
Turku, Finland). The results are expressed as the mean counts per minute (cpm) of 
triplicate cultures f standard error of the mean @EM). 
Antigens. Cell wall fragments of ECW and Streptococcus pyogenes (SCW) were 
prepared as described previously (14,23). PPCs were isolated from the normal human 
feces or from ileostomy fluid according to procedures described by Haze&erg et al. 
(28). Muramyl dipeptide (MDP) and concanavalin A (Con A) were purchased from 
Sigma (St. Louis, MO). The 65-kDa protein was a kind gift of Dr. J. D. A. van Embden, 
RIVM, Bilthoven, The Netherlands. 
Phenotyping of the cell lines. The phenotype of the cells lines was determined by 
FACScan analysis using ascites of the monoclonal antibodies ER- 1, ER-2, 0x-6, Ox- 
8, and ED- 1 and culture supernatants of Mark-l or R73. All monoclonals were a kind 
gift of Dr. J. Rozing, TNO-IVEG, Rijswijk, The Netherlands. The FACScan analysis 
was performed of Ficoll gradient-separated cells 3 days after the last restimulation 
in vitro. 
Ankle joint injection. Injection of 15 pg ECW (based on muramic acid content) in 
50 ~1 BSS into the right ankle joint or as a control of 50 ~1 BSS into the left ankle 
joint was performed under ether anesthesia. The ECW or BSS were administered into 
the heel of the feet by injection through the Achilles tendon. 
Measurement of ankle joint diameter. The diameter of the ankle joints of the hind 
paws was measured with a vernier caliper. 
99mTechnetium-pertechnetate sc nning. The rats were injected subcutaneously with 
18.5 MBq 99mtechnetium-pertechnetate. Af r 1 hr the rats were sedated and images 
were acquired with a gamma camera fitted with a low-energy all purpose collimator. 
The images were acquired in a 128 X 128 matrix. 
Histology. Knee joints were removed and fixed in 4% paraformaldehyde and de- 
calcified in 5% formic acid during 2 weeks. Five-micrometer sections were made and 
stained with hematoxylin and eosin. 
RESULTS 
Injection of ECW ip (22-24) or in IFA in the base of the tail (to be published) 
causes a chronic arthritis that lasts for several months and often does not wane com- 
pletely. 
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We isolated a T cell line (B 13) from the peripheral ymph nodes (LN) of Lewis rats 
12 days after ip injection of ECW. B19 was isolated from the LN of a Lewis rat 12 
days after injection of ECW/IFA in the base of the tail. 
The arthritogenic capacity of B13 and B19 was tested in syngeneic recipients. A 
summary of the various in vivo experiments is shown in Table 1. Experiment I shows 
that ankle joint inflammation was found 6 days after iv injection of 6 X 10’ B 13 cells 
into 6.0 Gy-irradiated Lewis recipients. The kinetics of the inflammatory swellings of 
the ankle joints of the rats of Experiment I of Table 1 are shown in Fig. 1. B 13 was 
iv injected into five irradiated Lewis rats. These rats received 15 pg of ECW in 50 ~1 
in the right ankle joint; 50 ~1 of BSS was injected into the left ankle joint. Another 
group of irradiated Lewis rats received the same ankle joint injections, but no B 13 
cells. Injection of ECW into the right ankle joint already resulted in an ankle joint 
swelling (Fig. lc). From Fig. lb, however, it can be seen that also in the left ankle 
joints where no ECW was injected an inflammation could be found in three out of 
five of the B 13-injected rats. This is the incidence as indicated in Table 1, Experiment 
I. Local injection of ECW into the right ankle joint without iv injection of B13 did 
not result in inflammation of the left ankle joint of the rats (Fig. Id). 
In the Experiments II-VII described below, no more additional ankle joint injections 
were performed. 
Joint inflammation was not seen when the recipients were not irradiated (Table 1, 
Experiment II). Inflammation of the ankle joints was also observed when B13 cells 
were injected after stimulation for 4 weeks by syngeneic spleen cells alone without 
additional antigen (Experiment III). No joint inflammation was seen when 30 Gy- 
irradiated cells were injected (Table 1, Experiment IV). In Experiment V the inflam- 
matory swelling was not located in the ankle joints but in the knee joints as was found 
upon palpation 2 weeks after intravenous injection of 8 X 10’ B 13 cells in five of the 
seven irradiated (6 Gy) Lewis rats treated. As a knee joint inflammation, because of 
its location, is not measurable with a vernier caliper we made this inflammation visible 
TABLE 1 
Summary of the in Vivo Experiments Using B 13 
Experiment 
Cell 
line 
No. of Cells Recipients 
cells irradiated Recipients irradiated Onset Localization Incidence 
I B13 6X 10’ 
II B13 4x IO’ 
III+ B13 5.6 X 10’ 
IV B13 7.5 x 10’ 
B13 7.5 x 10’ 
V B13 8X IO’ 
VI B13 7 x 10’ 
B13 7x 10’ 
Con A 6X 10’ 
Con A 6X 10’ 
VII B19 6X IO’ 
- Lewis 
- Lewis 
- Lewis 
- Lewis 
30 Gy Lewis 
- Lewis 
- Lewis 
- F344 
- Lewis 
- F344 
- LCWiS 
6.0 Gy 
6.5 Gy 
6.5 Gy 
6.5 Gy 
6.0 Gy 
6.0 Gy 
6.0 Gy 
6.0 Gy 
6.0 Gy 
6.0 Gy 
d6 
- 
dll 
dll 
- 
d12 
dl 
- 
- 
d14 
Ankles 
Ankles 
Ankles 
- 
Knees 
Knees (+ ankles) 
- 
- 
Ankles (+ knees) 
315 
015 
215 
215 
O/5 
517 
515 (215) 
O/5 
O/5 
015 
215 (l/5) 
Note. Cells were iv injected 4 days after restimulation, on day 3 40-100 U/ml reclL-2 was added. Asterisk 
indicates that in this experiment the B13 cells were restimulated for 4 weeks without additional antigen, 
with syngenous spleen cells alone. Con A cells were LN cells from a naive Lewis rat cultured for 2 weeks 
on Con A. 
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FIG. I. Ankle diameters of irradiated Lewis rats after iv injection of B13 and local injection of ECW. (a, 
b) 5.6 X 10’ B 13 cells/rat were iv injected into five irradiated (6 Gy) rats. Into the right ankle joints 15 pg 
of ECW in 50 pl and into the left ankle joints 50 pl of BSS was injected. (c, d) Five irradiated (6 Gy) rats 
were injected with 15 pg ECW in 50 pl into the right ankle joints and 50 pl BSS into the left ankle joints. 
Ankle joint diameters were measured with a vernier caliper. 
by a 99mtechnetium (Tc)-pertechnetate uptake technique. Two of the arthritic rats of 
Table 1, Experiment V, were scanned by a this technique at Day 14 after injection of 
the T cell line. One rat showed a clear swelling in both knee joints (Fig. 2a), whereas 
the rat of Fig. 2b showed an increased Tc-uptake in the left knee joint, as compared 
to the scanning pattern of a naive Lewis rat (Fig. 2~). This swelling could not be 
detected any longer by this scanning method 2 1 days after injection of B13. 
Histological examination of the knee joints of three of the arthritic rats of Exp. V 
was performed at Days 13, 15, and 27 after injection of B 13. Inflammatory infiltrates 
consisted of large numbers of mononuclear cells, but also of granulocytes. The bone 
between marrow spaces was severely damaged and the marrow showed regenerative 
activity (Fig. 2d). The cartilage appeared practically undamaged. At Day 15 the his- 
tology was comparable to that at day 13. At Day 27 there was only a small inflammatory 
infiltrate left (data not shown). 
Injection of Con A-stimulated naive LN cells into 6 Gy-irradiated rats did not result 
in disease (Experiment VI). Histological features as described above were also not 
observed. An interesting observation was made in this experiment (VI). In this ex- 
periment the irradiated five Lewis rats all developed knee joint inflammation, whereas 
none of the irradiated F344 rats that are largely RTl identical to Lewis rats did. The 
occurrence of knee joint inflammation correlated with illness and weight loss up to 
20% of the original body weight (Fig. 3). In contrast to the Lewis rats, the F344 rats 
did not lose weight and administration of Con A-cultured control cells did also not 
result in weight loss. 
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FIG. 2. (a, b, c) 99mTechnetium-pertechnetate scanning of BlS-injected rats. 8 X 10’ B13 cells/rat were 
injected into seven irradiated (6 Gy) rats. B13 cells were restimulated for 3 days with 3 X IO5 syngeneic 
spleen cells and 30 &ml ECW and 1 day with additional 40 U/ml recIL-2. Fourteen days later two of the 
rats (a, b) and one naive rat (c) were scanned with a gamma camera. The order in the representation of 
increasing levels of radiation is from black to grey to white. By a computer threshold very high activity levels 
were eliminated (black in the abdomen). The tails of the rats were used as reference for matching the level 
of the y radiation emitted by the rats. Rat a suffered from joint inflammation in both knee joints, rat b in 
the left knee joint (arrows). (d) Histological examination of a knee joint of a B 13 injected rat at Day 13 after 
iv injection of B13. P, patella; F, femur; JS, joint space. Magnification: 40X. 
In Experiment VII of Table 1, 7 X lo7 B19 cells were injected. Fourteen days later 
two of the five rats suffered from ankle joint inflammation. One of these rats also had 
knee joint inflammation in both knee joints, indicating that B13 was not our only T 
cell line capable of inducing arthritis. 
The helper phenotype of the B 13 and B19 cell lines was asserted by FACScan 
analysis. Both bear an (YP T cell receptor as they are positive for the monoclonal R73 
(30) (Table 2). Three days after restimulation only a small percentage of the cells was 
class II positive, as was determined by the monoclonal Ox-6 (Table 2). The rather 
high percentage Mark-l positive cells might be caused by the presence of irradiated 
spleen B cells 3 days after the restimulation. 
In a proliferation assay the specificity of the cell lines was tested. As shown in Table 
3, extensive proliferation of BI 3 and B 19 was found when syngeneic spleen cells as a 
source of antigen presenting cells were added alone. Being aware of the possibility 
that antigen carry-over could be the reason for this, we cultured the B13 cells for 4 
weeks by weekly restimulation with syngeneic spleen cells. At the end of these 4 weeks 
the cells were diluted about 600 times without the addition of antigen. In a proliferation 
assay (Table 3, ECW) B13 cells were still found to proliferate on syngeneic spleen 
cells. Moreover, we were able to culture this B13 cell line continuously for 5 months 
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FIG. 3. Mean weights (+SEM) of five Lewis rats after injection of 7 X 10’ B13 cells (0), five Lewis rats 
after injection of 6 X 10’ Con A-cultured control cells (O), five F344 rats after injection of 7 X 10’ B13 cells 
(O), and five F344 rats after injection of 6 X IO’ Con A cells (m). All rats were 6.0 Gy-irradiated. 
by a weekly restimulation with syngeneic spleen cells followed by addition of recom- 
binant IL-2 3 days later. Also in serum-free medium (IMDM-ATL (3 1)) or medium 
supplemented with 2% normal rat serum a good proliferation was found on syngeneic 
spleen cells alone, suggesting that this proliferation is not caused by recognition of a 
fetal calf serum component (data not shown). 
In several experiments we found that addition of intestinal flora derived soluble 
PPC isolated from normal human feces (28) gave a higher stimulation of B 13 or B 19 
compared to the stimulation by syngeneic spleen cells alone. In Fig. 4a we show the 
dose-response relationship of the proliferation of the B 13 cell line on PPC. A control 
cell line (naive LN T cells, stimulated for several weeks with Con A) did not respond 
to PPC, showing that PPC has no mitogenic effect on these cells. Both B 13 and the 
Con A line, however, responded well to Con A (not shown). Moreover, a T cell line 
reactive with myelin basic protein (Z line (32)) was unresponsive to PPC (W. van 
Eden, personal communication). Figure 4b shows the additional stimulation of PPC 
TABLE 2 
Phenotype of B 13 and B 19 Determined by FACScan Analysis, 
3 Days after the Last Restimulation of the T Cell Lines 
Monoclonal antibody Marker B 13 % positive B 19 % positive 
ER-l pan-T cells 94.2 96.4 
Mark- 1 B cells 11.8 11.2 
ER-2 CD4 90.4 92.7 
OX-8 CD8 2.4 2.2 
ED- 1 M0 3.2 1.9 
OX-6 Class I 19.4 9.1 
R73 & T cell receptor 86.7 96.3 
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TABLE 3 
Proliferationassay of B 13 and B19 Cultured with and B 13 Cultured without ECW 
Antigen 
B13 (+ECW) 
cpm X 10e3 
B13 (-ECW) 
cpm X 10m3 
B19 
cpm X 10m3 
ECW 30 13.6 f 0.6 
sew 30 13.1 f I.0 
PPC 30 27.5 f 2.8 
MDP 30 12.1 f 3.7 
65 kDa 10 14.1 + 1.7 
Con A 1 16.7 f 0.5 
-(syngeneic spleen) 19.1 + 2.2 
- 0.1 f 0.0 
9.3 + 2.6 
14.7 + 0.2 
12.4 + 1.2 
15.7 + 2.2 
15.7 + 1.2 
14.4 z!z 0.7 
13.0 xi 0.6 
0.1 2 0.1 
49.1 + 3.9 
29.0 f 2.1 
50.2 zk 1.4 
NT 
29.4 f 1.6 
58.5 k 6.8 
29.9 k 0.9 
0.4 + 0.1 
Note. 2 X IO4 cells per well were tested and 6 X lo4 syngeneic spleen cells were added in the presence of 
various antigens. In the proliferation assay of B 13 cells cultured without ECW, the cells were restimulated 
for 4 weeks by addition of 3 X 10’ syngeneic spleen cells/ml, followed 3 days later by transferring to CM 
containing 40-100 U/ml IL-2. The results are expressed as the mean counts per minute (cpm) of triplicate 
cultures + SEM. NT, not tested. 
in a dose-response curve of the syngeneic spleen cells. An additional response by PPC 
was also observed in the case that high doses of antigen presenting cells were used for 
stimulation. 
As it is possible that the B 13 cell line is a mixture of cells that recognize syngeneic 
cells and cells that recognize PPC, a subclone of B 13 was produced by limiting dilution 
on syngeneic spleen cells, without additional antigen. The lOC8 (cloned at 10 cells/ 
well with a cloning efficiency of 38%, so statistically a clone) showed the same stim- 
0 0.1 0.3 1 3 IO 30 100 
pg/ml PPC 
l(r 3x104 105 3x105 106 3x106 
# syngeneic spleen cells 
FIG. 4. (a) Dose-response curve of PPC. Proliferation of 2 X 10“ cells/well in the presence of various 
doses of PPC and 3 X lO’/ml syngereic spleen cells. (0) B13, (0) Con A-cultured LN cells. (b) Dose- 
response curve of syngeneic spleen cells. Proliferation of 2 X lo4 cells/well in the presence of either increasing 
numbers of syngeneic spleen cells (A) or with additional 30 ccg/ml PPC (A.). The results are expressed as the 
mean counts per minute (cpm) of triplicate cultures +SEM. 
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ulation pattern as the B13 line (PPC, 7030 + 1488 cpm; Con A, 10735 +- 2243 cpm; 
syngeneic spleen cells, 4285 f 557 cpm; without additional stimulation, 68 + 7 cpm). 
Next we determined whether the recognition of the spleen cells and PPC by B 13 is 
MHC restricted. In Table 4 Experiment I, we show that spleen cells from F344 rats, 
which are also RTl’ like the Lewis rat, but are insusceptible to arthritis induction by 
bacterial antigens, stimulated B13 as well. Spleen cells from RP rats (RT1A”B’) also 
stimulated B13. Wag spleen cells (RTl”), however, were unable to stimulate B13, 
independent of addition of PPC. Addition of syngeneic Lewis spleen cells to the Wag 
spleen cells again stimulated B 13. These results demonstrate that the recognition of 
spleen cells and PPC by B 13 is MHC class II restricted. A third experiment (Table 4, 
Experiment III) showed that spleen cells from germ-free (GF) F344 rats were also able 
to stimulate B 13. 
In conclusion, B 13 and B 19 are arthritogenic helper T cell lines. B 13 shows class 
II restriction and is additionally stimulated by PPC isolated from the human intestinal 
contents. 
DISCUSSION 
This report describes T cell lines (B13, B19) isolated from Lewis rats, treated with 
an arthritogenic dose of E. aerofaciens. These cell lines cause arthritis after iv injection 
in irradiated Lewis recipients. Arthritogenic T cell lines have been described that are 
specific for bacterial antigens. The A2b cell line, for example, is directed against the 
65-kDa protein of hf. tuberculosis and is thought to be arthritogenic because of cross- 
reactivity between the 65-kDa protein and cartilage (11, 12) or because of cross-reac- 
tivity between exogenous and endogenous heat shock proteins (13). An arthritogenic 
T cell line that recognizes treptococcal cell walls has been published (18) that does 
TABLE 4 
Restriction Pattern of B I3 and Antigen Presentation by Spleen Cells from Germ-free (GF) F344 Rats 
Antigen cpm X 10m3 
Experiment Spleen ECW 30 PPC 30 Con A - 
I Lewis 
F344 
RP 
II 
III 
- 
Lewis 
Wag 
Wag + Lew 
- 
Lewis 
F344-GF 
- 
24.2 f 6.7 
35.5 f 3.1 
48.2 + 1.7 
NT 
25.2 f 0.1 
1.6 f 0.6 
14.4 f 0.6 
NT 
15.8 2 1.2 
21.1 f 1.1 
NT 
40.0 + 3.6 
46.6 + 3.0 
55.1 f 2.1 
NT 
19.4 f 0.8 
1.6 f 0.1 
NT 
NT 
13.1 + 2.2 
28.0 f 2.8 
NT 
29.1 f 2.9 39.5 ic 1.7 
39.1 f 3.1 41.5 + 0.6 
33.2 f 2.0 42.1 + 3.0 
NT 1.6 + 1.1 
18.1 + 1.8 19.7 + 1.0 
28.8 f 8.2 0.2 + 0.1 
24.3 f 1.3 15.3 + 0.4 
NT 0.2 AZ 0.1 
2.0 f 0.2 12.8 f 0.3 
3.6 f 0.3 15.6 f 0.7 
NT 0.1 f 0.0 
Note. GF F344 spleen cells were used after storage in liquid Nz Spleen cells were tested at 3 X 1 OS cells/ 
ml. In the case when Wag and Lewis spleen cells were tested, 1.5 X 1 O5 cells/ml of both were pooled. The 
antigen concentrations used are depicted in &ml in front of the antigen. In this experiment he Con A 
batch used was not optimal. The results are expressed as the mean counts per minute (cpm) of triplicate 
cultures f SEM. NT, not tested. 
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not recognize the 65-kDa protein. The arthritogenic B13 and B19 cell lines that are 
described here differ from those lines as they exhibit a more autoimmune-like character. 
Autoreactive T cell lines have also been described by others (33, 34), they however 
did not study the in vivo capacities of these cell lines. The recently described murine 
autoreactive T cell line that was shown to recognize the 65-kDa protein of M. bovis, 
as it was additionally stimulated by this protein, is of interest (35). The B13 and B19 
T cell lines that are described here are not additionally stimulated by the 65-kDa 
protein as can be seen in Table 3. 
Intravenous injection of B 13 cells in irradiated Lewis rats resulted in ankle or knee 
joint inflammation l-2 weeks after treatment. In two experiments (Table 1, Experi- 
ments IV and VII) we saw ankle as well as knee joint inflammation. We cannot explain 
these differences in location of the inflammation. In the ECW-induced arthritis we 
also observe that the ankle joint inflammation in some cases is accompanied by knee 
joint inflammation. 
In most of the experiments described in Table 1 the recipients were irradiated sub- 
lethally (6.0-6.5 Gy). In the one experiment (Experiment II) in which we did not 
irradiate the recipients we did not see joint inflammation, but fewer B 13 cells were 
injected there. In the MT model using the A2b T cell line, arthritis was also induced 
only in irradiated recipients (9). 
In order to exclude that the arthritis was induced by bacterial antigen that was still 
present in the inoculum, and not by B13, we restimulated the B 13 cells for 4 weeks 
by syngeneic spleen cells without additional antigen before iv injection. Table 1, Ex- 
periment III, shows that we were still able to induce arthritis in this way. The cells 
were diluted about 600 times without antigen before in vivo injection. The 5.6 X 10’ 
cells injected per rat were cultured in 200 ml medium originally derived from 0.3 ml 
culture medium with antigen. Culture medium (0.3 ml) contains 9 pg ECW. The cells 
were washed extensively before injection, so it is unlikely that all the ECW are still 
present after this treatment. Even if all the ECW would be still present, maximally 9 
pg ECW could be iv-injected in the rats of Experiment III. Moreover, 30 Gy-irradiated 
B13 did not induce arthritis in Experiment IV, whereas the nonirradiated B13 cells 
did. In the case that irradiated B 13 cells were injected the animals did not show any 
illness or weight loss, in contrast o the rats injected with nonirradiated B 13 cells. This 
minimizes the probability that the arthritis was induced by bacterial antigens and not 
by our T cell line. 
F344 rats that are also RTl’ as are the Lewis rats, but differ from Lewis rats in the 
RT6 complex and have been described to differ in their hormonal levels (36, 37), are 
normally insusceptible to chronic arthritis induction by bacterial antigens. This is the 
case in the M. tuberculosis model (38), the S. pyogenes model (39), as well as in our 
model using E. aerofaciens (data not shown). It is not clear whether this insusceptibility 
is caused by the absence of the T cells that are involved in the induction of the arthritis 
or alternatively by a suppressor mechanism (40,41). We show here that the injection 
of arthritogenic T cells does not cause arthritis in irradiated F344 rats, favoring the 
second possibility. It is however not certain whether the Lewis cells can survive in the 
irradiated F344 rats. We are planning to investigate this in the near future. 
In the in vitro experiments we show that B13 and B19 proliferate after stimulation 
with syngeneic spleen cells. B 13 could also be stimulated by syngeneic LN cells, thy- 
mocytes, or peripheral blood cells (data not shown). PPC, isolated in soluble form 
from feces, gave an additional stimulation in most experiments. The ECW did not 
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show an additional stimulation, probably due to the insoluble character of this prep- 
aration. 
As B 13 is a cell line and not a clone and as we did not observe additional proliferation 
on PPC of B13 cells cultured without ECW (Table 3, ECW), we cannot exclude here 
that B 13 is in fact a mixture of at least two cell lines, one recognizing syngeneic spleen 
cells and one recognizing PPC. The proliferation experiment of subclone lOC8, how- 
ever, showed that the recognition of syngeneic spleen cells and the additional stimu- 
lation by PPC was also found at the clonal level. This clone, unfortunately, did not 
grow well enough to test the in vivo capacities of the cells. 
In Table 4 we show the recognition by B13 is MHC class II restricted. The B13 
cells proliferated when RT 1 B’ was present. The absence of proliferation on Wag (RT 1”) 
cells was restored by addition of Lewis spleen cells, indicating that the B 13 cells were 
still responsive in the presence of the Wag cells. 
As it could be assumed that B13 reacts with bacterial antigens, we investigated 
recognition of spleen cells of GF rats. We used GF F344 spleen cells (GF Lewis rats 
were not available) that appeared to stimulate B13 also. In sera of these GF rats, 
however, anti-PPC titers were found (also IgG and IgA) (data not shown), indicating 
that they meet this antigen, probably due to food constituents. In our opinion these 
rats are germ-free and not free from bacterial antigens. Moreover, we found that 
monoclonal antibodies raised against PPC recognize a subpopulation of acid phos- 
phatase positive macrophages in the red pulp of the spleen of these GF F344 rats (to 
be published). 
At present we are investigating the structures that are recognized by B 13 and B 19 
on the syngeneic spleen cells. Bjorkman et al. (42) have reported the presence of 
peptides in the MHC molecules. The T cell lines we describe here might recognize 
the MHC class II molecules or peptides that are present in the cleft of these molecules. 
It could be speculated that the recognition by B13 and B19 is based on the presence 
of bacterial antigens such as PPC on antigen presenting cells in vim We believe that 
intestinal PPC is most interesting in the etiology and the pathogenesis of arthritis as 
humans and animals are in continuous close contact with these antigens and invariably 
have high antibody titers against hese antigens (Haze&erg, personal communication). 
Our data suggest hat Lewis rats are T cell high responders to these antigens. This is 
in agreement with our observation that T cell lines can be isolated from the LN of 
naive Lewis rats by culture on syngeneic spleen cells in the presence of ECW or PPC. 
We are currently investigating the arthritogenic properties of these lines. We were, 
however, unable to culture T cell lines in this way from the LN of arthritis insusceptible 
F344, neither from naive rats nor from rats injected with ECW. Bulk cultures of LN 
cells of naive rats weekly restimulated by syngeneic spleen cells without ECW or PPC 
died after 2 to 3 weeks. We hypothesize that bacterial antigens from the normal en- 
dogenous flora can be present in the cleft of the MHC molecule in vivo and can 
therefore stimulate B13 and B19. Bacterial cell wall components (muramic acid) can 
indeed be detected in normal mammalian tissues such as liver, kidney, and brain (43, 
44). Granfors et al. (45, 46) have published the presence of Salmonella or Yersinia 
antigens in the joints of patients suffering from joint disease after infection with these 
bacteria. Bacterial antigens from the intestinal flora, with which we are in lifelong 
close contact might cause tolerance in the normal situation. After a booster with 
bacterial antigens this tolerance might be broken. 
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In any case the data presented here show that autoreactive T cells can be found 
after stimulation by intestinal bacterial cell wall antigens and that these T cells can be 
arthritogenic. This suggests a role for T cells with this type of reactivity in the induction 
of rheumatic disease. 
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